RandallSDavisMD

PubMed

• 1 citations
  HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44Natural Killer Cells in Ulcerative Colitis.
  Martin E Baumdick, Annika Niehrs, Frauke Degenhardt, Maria Schwerk, Ole Hinrichs, Ana Jordan-Paiz, Benedetta Padoan, Lucy H M Wegner, Sebastian Schloer, Britta F Zeche...> ;Gastroenterology. 2023 Oct 1
• 1 citations
  Evidence for Extensive Duplication and Subfunctionalization ofin Armadillo ().
  Maria Carolina Matos, Ana Pinheiro, Randall S Davis, Pedro J Esteves> ;International Journal of Molecular Sciences. 2023 Feb 25
• 41 citations
  Predictors of Nonseroconversion after SARS-CoV-2 Infection.
  Weimin Liu, Ronnie M. Russell, Frederic Bibollet-Ruche, Ashwin N Skelly, Scott Sherrill-Mix, Drew A Freeman, Regina Stoltz, Emily Lindemuth, Fang-Hua Lee, Sarah Sterre...> ;Emerging Infectious Diseases. 2021 Jun 30
• 7 citations
  Evolution of Fc Receptor-Like Scavenger in Mammals.
  Maria Carolina Matos, Ana Acacia S. Pinheiro, José Melo-Ferreira, Randall S. Davis, Pedro J. Esteves> ;Frontiers in Immunology. 2021 Feb 23
• 21 citations
  Convalescent Plasma-Mediated Resolution of COVID-19 in a Patient with Humoral Immunodeficiency
  Kazuhito Honjo, Ronnie M. Russell, Ran Li, Weimin Liu, Regina Stoltz, Edlue M. Tabengwa, Yutao Hua, Lynn Prichard, Ashton Kornbrust, Sarah Sterrett, Marisa B. Marques,...> ;Cell Reports. Medicine. 2021 Jan 19
• 14 citations
  Roles for the FCRL6 Immunoreceptor in Tumor Immunology.
  Randall S. Davis> ;Frontiers in Immunology. 2020 Oct 14
• 6 citations
  Fc Receptor-Like 6 (FCRL6) Discloses Progenitor B Cell Heterogeneity That Correlates With Pre-BCR Dependent and Independent Pathways of Natural Antibody Selection.
  Kazuhito Honjo, Woong-Jai Won, Rodney G. King, Lara Ianov, David K. Crossman, Juliet L. Easlick, Mikhail A. Shakhmatov, Mohamed Khass, Andre M. Vale, Robert P. Stephan...> ;Frontiers in Immunology. 2020 Feb 14
• 91 citations
  Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology
  William G. Wierda, John C. Byrd, Jeremy S. Abramson, Syed Bilgrami, Greg Bociek, Danielle M. Brander, Jennifer R. Brown, Asher Chanan-Khan, Julio C. Chavez, S. E. Cout...> ;Journal of the National Comprehensive Cancer Network. 2020 Feb 1
• 9 citations
  Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status.
  Lauren Shea, Kazuhito Honjo, David T. Redden, Edlue M. Tabengwa, Ran Li, Fu Jun Li, Mikhail A. Shakhmatov, Nicholas Chiorazzi, Randall S. Davis> ;Blood Cancer Journal. 2019 May 15
• 100 citations
  Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.
  Douglas B. Johnson, Mellissa J. Nixon, Yu Wang, Daniel Y. Wang, Emily Castellanos, Monica V. Estrada, Paula I. Ericsson-Gonzalez, Candace H Cote, Roberto Salgado, Viol...> ;JCI Insight. 2018 Dec 20
• 37 citations
  Plasmodium-specific atypical memory B cells are short-lived activated B cells.
  Damián Pérez-Mazliah, Peter Gardner, Edina Schweighoffer, Sarah McLaughlin, Caroline Hosking, Irene Tumwine, Randall S. Davis, Alexandre J. Potocnik, Victor L. J. Tybu...> ;Elife. 2018 Nov 2
• 8 citations
  Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary education.
  Gabrielle B. Rocque, Courtney P. Williams, Karina I. Halilova, Uma Borate, Bradford E. Jackson, Emily Sherene Van Laar, Maria Pisu, Thomas W. Butler, Randall S. Davis,...> ;Translational Behavioral Medicine. 2018 Mar 1
• 27 citations
  Hairy cell Leukemia, Version 2.2018: Clinical practice guidelines in oncology
  William G. Wierda, John C. Byrd, Jeremy S. Abramson, Seema A. Bhat, Greg Bociek, Danielle M. Brander, Jennifer R. Brown, Asher Chanan-Khan, S. E. Coutre, Randall S. Da...> ;Journal of the National Comprehensive Cancer Network. 2017 Nov 1
• 4 citations
  Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia.
  Lauren Shea, Fady M. Mikhail, Andres Forero-Torres, Randall S. Davis> ;Clinical Case Reports. 2017 Apr 24
• 19 citations
  FCRL regulation in innate-like B cells
  Randall S. Davis> ;Annals of the New York Academy of Sciences. 2015 May 11
• Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
  Racquel Innis-Shelton, Randall S. Davis, Lawrence S. Lamb, Shin Mineishi> ;Leukemia & Lymphoma. 2015 Jan 8
• 43 citations
  Emerging Roles for the FCRL Family Members in Lymphocyte Biology and Disease
  Fu Jun Li, Woong-Jai Won, E. J. Becker, Juliet L. Easlick, Edlue M. Tabengwa, Ran Li, Mikhail A. Shakhmatov, Kazuhito Honjo, Peter D. Burrows, Randall S. Davis> ;Current Topics in Microbiology and Immunology. 2014 Jan 1
• 45 citations
  FCRL3 promotes TLR9‐induced B‐cell activation and suppresses plasma cell differentiation
  Fu Jun Li, Daniel M. Schreeder, Ran Li, Jiongru Wu, Randall S. Davis> ;European Journal of Immunology. 2013 Nov 1
• 25 citations
  FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling
  Zilu Zhu, Ran Li, Hao Li, Tong Zhou, Randall S. Davis> ;Proceedings of the National Academy of Sciences of the United States of America. 2013 Apr 2
• ?-Funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.
  Davis, R. L.,Das, S.,Buck, D. J.,Stevens, C. W.> ;Neurochem Int. 2013 Mar
• 86 citations
  FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling
  Hae Won Sohn, Peter D. Krueger, Randall S. Davis, Susan K. Pierce> ;Blood. 2011 Dec 8
• 25 citations
  Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia
  Fu Jun Li, Yoshiki Kubagawa, Matthew K. McCollum, Landon Wilson, Tomoko Motohashi, Luigi F. Bertoli, James C. Barton, Stephen Barnes, Randall S. Davis, Hiromi Kubagawa> ;Blood. 2011 Nov 3
• 4 citations
  Unraveling the Molecular Pathogenesis of Chronic Lymphocytic Leukemia: Dissecting a MicroRNA Regulatory Network
  Daniel J. Allendorf, Randall S. Davis> ;JAMA. 2011 Jan 5
• 25 citations
  FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
  Teresa Santiago, Sergei V. Kulemzin, Evdokia S. Reshetnikova, Chikaev Na, Olga Y. Volkova, Ludmila V. Mechetina, Meina Zhao, Randall S. Davis, Alexander V. Taranin, Al...> ;International Immunology. 2011 Jan 1
• 43 citations
  FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells
  Tanisha Anne Jackson, Christopher L. Haga, Götz R. A. Ehrhardt, Randall S. Davis, Max D. Cooper> ;Journal of Immunology. 2010 Dec 15
• Join now to see all